Search results
Showing 1216 to 1230 of 2006 results for nice guidelines
NICE has developed a medtech innovation briefing (MIB) on DuraGraft for preserving vascular grafts .
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules (HTG611)
Evidence-based recommendations on EarlyCDT Lung for assessing the risk of lung cancer in solid lung nodules.
The standing committees were responsible for the development of our public health guidance.
The standing committees were responsible for the development of our public health guidance.
of focal and generalised seizures since publication of the original NICE guideline on epilepsy in 2004 have not been...
NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma .
Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)
NICE has developed a medtech innovation briefing (MIB) on remote ECG interpretation consultancy services for cardiovascular disease .
Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy.
NICE has developed a medtech innovation briefing (MIB) on Acumen IQ sensor for predicting hypotension risk .
Home What NICE does Digital health...
Etanercept and efalizumab for treating moderate to severe plaque psoriasis (TA103)
Evidence-based recommendations on etanercept (Enbrel) for treating severe psoriasis in adults.
Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (HTG430)
Evidence-based recommendations on using immunohistochemistry or microsatellite instability testing to guide further testing for Lynch syndrome in people with colorectal cancer.
How to register with us as a diagnostic technologies stakeholder.
How to register with us as a diagnostic technologies stakeholder.